Rituximab + immunotherapy in follicular lymphoma
Condition:   Follicular Lymphoma Interventions:   Drug: Rituximab;   Drug: Utomilumab;   Drug: Avelumab;   Drug: PF04518600 Sponsors:   Dana-Farber Cancer Institute;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma
Condition:   Medullary Thyroid Carcinoma Intervention:   Other: PET at 18F-FDOPA Sponsor:   Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy for Gastric Cancer in China
Conditions:   Gastric Cancer;   Chemotherapy Effect Intervention:   Drug: Chemotherapy Sponsor:   LI CHEN Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer
Conditions:   Metastatic Breast Cancer;   Positive Hormonal Receptors Intervention:   Other: Quality of life in metastatic BC Sponsor:   Institut Cancerologie de l'Ouest Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
Conditions:   NSCLC;   Adenocarcinoma;   Squamous Cell Carcinoma Interventions:   Drug: Anlotinib combined with pemetrexed and carboplatin, phase I;   Drug: Anlotinib combined with paclitaxel and carboplatin, phase I;   Drug: Anlotinib combined with pemetrexed and carboplatin, phase II;   Drug: Anlotinib combined with paclitaxel and carboplatin, phase II Sponsor:   Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial
Condition:   Hepatocellular Carcinoma Interventions:   Device: Transcatheter arterial chemoembolization;   Device: radiofrequency ablation/microwave ablation Sponsor:   Fudan University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Diagnostic Significance of Single Center, Open and Prospective Evaluation of < Sup > 18 < Sup > F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
Conditions:   Positron-Emission Tomography;   Carcinoma, Hepatocellular Intervention:   Diagnostic Test: PET/CT dynamic scan Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients
Conditions:   Carcinoma;   Lung Cancer;   NSCLC;   Lung Neoplasm Intervention:   Sponsor:   Peking University People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer
Condition:   Pancreatic Cancer Interventions:   Drug: nanoparticle albumin-bound paclitaxel;   Drug: S1;   Drug: Gemcitabine Sponsor:   Peking University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Evaluation of NanoDoce ® in Participants With Urothelial Carcinoma
Conditions:   Bladder Cancer;   Urothelial Carcinoma;   Urinary Bladder Neoplasm;   Urinary Bladder Cancer;   Urogenital Neoplasms;   Urologic Neoplasms;   Urologic Cancer;   Malignant Tumor of the Urinary Bladder;   Cancer of the Bladder Interventions:   Drug: NanoDoce (direct injection);   Drug: NanoDoce (intravesical instillation);   Other: Institutional Standard of Care Sponsors:   NanOlogy, LLC;   US Biotes...
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Condition:   Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Interventions:   Drug: cabozantinib;   Drug: nivolumab Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Pet/mri (axumin) study of men with highly suspicious mri lesions that showed no clinically signiciant prostate cancer following mri fusion targeted biopsy
Condition:   Prostate Cancer Intervention:   Diagnostic Test: Fluciclovine PET/MRI Sponsor:   New York University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Breast: Recovery After Axillary Node Clearance - Evaluating Limbs With E-Technology (the BRACELET Study)
Conditions:   Breast Cancer;   Mobility Limitation Intervention:   Sponsor:   Imperial College London Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

The Application of 3T MRI in Esophageal Cancer
Conditions:   Esophageal Cancer TNM Staging;   Magnetic Resonance Imaging;   Prognosis Intervention:   Other: No intervention Sponsor:   Henan Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Cannabis Oil for Chronic Non-Cancer Pain Treatment
Condition:   Chronic Non-cancer Pain Interventions:   Drug: CBD;   Drug: CBD+THC;   Other: Placebo Sponsors:   Hamilton Health Sciences Corporation;   Michael G. DeGroote Institute for Pain Research and Care, McMaster University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)
Condition:   Cervical Cancer Interventions:   Biological: Pembrolizumab;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Carboplatin;   Biological: Bevacizumab;   Drug: Placebo to pembrolizumab Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer Interventions:   Drug: Paclitaxel;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Placebo Sponsor:   Hoffmann-La Roche Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

The Biomarker Analysis in Locally Advanced Cervical Cancer
Condition:   Uterine Cervical Neoplasms Intervention:   Sponsor:   Mackay Memorial Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma
Condition:   Squamous Cell Carcinoma of the Head and Neck Interventions:   Drug: Durvalumab;   Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Standard of Care Therapy Sponsors:   University of Colorado, Denver;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer
Condition:   Colorectal Cancer Interventions:   Drug: FOLFOX regimen;   Drug: Panitumumab;   Drug: Bevacizumab;   Drug: FOLFIRI regimen Sponsors:   Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD);   Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2018 Category: Research Source Type: clinical trials

MDM2 Inhibitor DS-3032b and Low-Dose Cytarabine in Treating Participants With Newly Diagnosed Recurrent or Refractory Acute Myeloid Leukemia
Conditions:   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Recurrent Acute Myeloid Leukemia;   Refractory Acute Myeloid Leukemia;   TP53 Gene Mutation Negative Interventions:   Drug: Cytarabine;   Drug: MDM2 Inhibitor DS-3032b Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer (NK)Cells
Conditions:   Lung Cancer;   Breast Cancer;   Colon Cancer;   Pancreatic Cancer;   Ovarian Cancer Intervention:   Biological: Activated NK Sponsor:   Xuanwu Hospital, Beijing Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Conditions:   RCC;   Clear Cell Renal Cell Carcinoma;   Kidney Cancer;   Renal Cancer;   Renal Cell Carcinoma;   Renal Cell Cancer Metastatic;   Renal Cell Carcinoma Recurrent;   Renal Cell Cancer, Recurrent;   Kidney Intervention:   Drug: PT2977 in combination with cabozantinib tablets Sponsor:   Peloton Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

MRI Guided Prostate Cancer Focal Laser Ablation
Condition:   Prostate Cancer Intervention:   Device: MRI Guided Focal Laser Interstitial Thermal Ablation Sponsor:   Emory University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation
Condition:   Recurrent Hepatocellular Carcinoma Intervention:   Biological: LioCyx Sponsors:   Lion TCR Pte. Ltd.;   Agency for Science, Technology and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients
Condition:   Cancer Interventions:   Other: mPCL;   Other: Usual Care Sponsors:   Susan Miesfeldt;   Maine Medical Center;   National Institutes of Health (NIH);   Dimagi Inc.;   Muhimbili University of Health and Allied Sciences;   John E. Fogarty International Center (FIC) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Conditions:   Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer;   Pancreatic Neoplasms Interventions:   Drug: PEGPH20;   Biological: Pembrolizumab Sponsors:   Pancreatic Cancer Research Team;   Merck Sharp & Dohme Corp.;   Halozyme Therapeutics;   University of Washington Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Pembrolizumab in Treating Participants With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules
Conditions:   Non-Small Cell Lung Carcinoma;   Pulmonary Nodule;   Stage I Lung Cancer AJCC v8;   Stage IA1 Lung Cancer AJCC v8;   Stage IA2 Lung Cancer AJCC v8;   Stage IA3 Lung Cancer AJCC v8;   Stage IB Lung Cancer AJCC v8;   Stage II Lung Cancer AJCC v8;   Stage  IIA Lung Cancer AJCC v8;   Stage IIB Lung Cancer AJCC v8 Interventions:   Other: B...
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
Conditions:   Human Papillomavirus-Related Carcinoma;   Human Papillomavirus-Related Cervical Carcinoma;   Stage IB2 Cervical Cancer AJCC v8;   Stage II Cervical Cancer AJCC v8;   Stage II Vaginal Cancer AJCC v8;   Stage IIA Cervical Cancer AJCC v8;   Stage IIA Vaginal Cancer  AJCC v8;   Stage IIA1 Cervical Cancer AJCC v8;   Stage IIA2 Cervical Cancer AJCC v8;   Stage IIB&...
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer
Conditions:   Rectal Cancer;   Metastasis;   Radiotherapy Intervention:   Combination Product: IMRT + oral chemotherapy Sponsor:   Institut Cancerologie de l'Ouest Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of IV Nerofe ™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
Conditions:   Metastatic Ovarian Cancer;   Triple Negative Breast Cancer Intervention:   Biological: Nerofe is a first in class derivative of a human hormon-peptide(TCApF), with Cancer suppressive properties. Sponsor:   Immune System Key Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Conditions:   Colorectal Cancer;   Colonic Neoplasms;   Rectal Neoplasms;   Colon Disease;   Colon Cancer;   Rectal Cancer;   Rectal Diseases Interventions:   Procedure: Single-incision Laparoscopic Surgery;   Procedure: Conventional Laparoscopic Surgery Sponsors:   Ruijin Hospital;   Changhai Hospital;   Fudan University;   RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2/Neu Negative;   Stage IV Breast Cancer AJCC v6 and v7 Interventions:   Drug: Palbociclib;   Drug: Letrozole;   Drug: Fulvestrant;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening
Condition:   Prostate Cancer Screening Intervention:   Other: Online training module Sponsor:   University of Malaya Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Conditions:   Cutaneous Melanoma;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Urothelial Carcinoma;   Renal Cell Carcinoma Interventions:   Biological: GEN-009 Adjuvanted Vaccine;   Drug: Nivolumab Sponsor:   Genocea Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Condition:   Lung Cancer (Diagnosis) Intervention:   Other: Blood Sample Collection Sponsor:   Exact Sciences Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Dynamic Focusing Evaluation for Prostate Cancer Treatment
Condition:   Cancer of Prostate Intervention:   Device: " Ablatherm Foc/Dyn " or " Focal One " HIFU treatment Sponsor:   EDAP TMS S.A. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
Conditions:   Breast Cancer;   HER2+ Breast Cancer Interventions:   Biological: VRP-HER2;   Biological: Pembrolizumab Sponsors:   Herbert Lyerly;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Web-based Information Tool to Support Treatment Choice in Advanced Cancer
Condition:   Advanced Pancreatic Cancer Intervention:   Other: web-based interactive tool Sponsors:   Bournemouth University;   Poole Hospital NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

MDM2 Inhibitor DS-3032b and Low-Dose Cytarabine in Treating Participants With Newly Diagnosed Recurrent or Refractory Acute Myeloid Leukemia
Conditions:   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Recurrent Acute Myeloid Leukemia;   Refractory Acute Myeloid Leukemia;   TP53 Gene Mutation Negative Interventions:   Drug: Cytarabine;   Drug: MDM2 Inhibitor DS-3032b Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Web-based Information Tool to Support Treatment Choice in Advanced Cancer
Condition:   Advanced Pancreatic Cancer Intervention:   Other: web-based interactive tool Sponsors:   Bournemouth University;   Poole Hospital NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
Conditions:   Breast Cancer;   HER2+ Breast Cancer Interventions:   Biological: VRP-HER2;   Biological: Pembrolizumab Sponsors:   Herbert Lyerly;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Dynamic Focusing Evaluation for Prostate Cancer Treatment
Condition:   Cancer of Prostate Intervention:   Device: " Ablatherm Foc/Dyn " or " Focal One " HIFU treatment Sponsor:   EDAP TMS S.A. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Condition:   Lung Cancer (Diagnosis) Intervention:   Other: Blood Sample Collection Sponsor:   Exact Sciences Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Conditions:   Cutaneous Melanoma;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Urothelial Carcinoma;   Renal Cell Carcinoma Interventions:   Biological: GEN-009 Adjuvanted Vaccine;   Drug: Nivolumab Sponsor:   Genocea Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening
Condition:   Prostate Cancer Screening Intervention:   Other: Online training module Sponsor:   University of Malaya Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2/Neu Negative;   Stage IV Breast Cancer AJCC v6 and v7 Interventions:   Drug: Palbociclib;   Drug: Letrozole;   Drug: Fulvestrant;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Conditions:   Colorectal Cancer;   Colonic Neoplasms;   Rectal Neoplasms;   Colon Disease;   Colon Cancer;   Rectal Cancer;   Rectal Diseases Interventions:   Procedure: Single-incision Laparoscopic Surgery;   Procedure: Conventional Laparoscopic Surgery Sponsors:   Ruijin Hospital;   Changhai Hospital;   Fudan University;   RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of IV Nerofe ™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
Conditions:   Metastatic Ovarian Cancer;   Triple Negative Breast Cancer Intervention:   Biological: Nerofe is a first in class derivative of a human hormon-peptide(TCApF), with Cancer suppressive properties. Sponsor:   Immune System Key Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer
Conditions:   Rectal Cancer;   Metastasis;   Radiotherapy Intervention:   Combination Product: IMRT + oral chemotherapy Sponsor:   Institut Cancerologie de l'Ouest Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials